BACKGROUND: Much effort has been made to study first-ever stroke patients. However, recurrent stroke has not been investigated as extensively. It is unclear which risk factors dominate, and whether adequate secondary prevention has been provided to patients who suffer from recurrent stroke. Also, the different types of recurrent stroke need further evaluation. METHODS: The study included patients with recurrent stroke admitted to twenty-three Swedish stroke centers. The type of previous and recurrent stroke was determined, as well as evaluation (when applicable) of recurrent ischemic stroke according to the TOAST classification. Presence of vascular risk factors was registered and compared to the type of stroke. Also assessed was ongoing secondary prevention treatment at recurrent stroke onset. RESULTS: A total of 889 patients with recurrent stroke (mean age 77) were included in the study. Of these, 805 (91%) had ischemic stroke, 78 (9%) had intracerebral hemorrhage and 6 (<1%) stroke of unknown origin. The most frequent vascular risk factors were hypertension (75%) and hyperlipidemia (56%). Among the 889 patients, 29% had atrial fibrillation. Of the patients in the ischemic group with cardiac embolism, only 21% were on anticoagulation treatment. The majority of the patients (75%) had their most recent previous stroke >12 months before admission. CONCLUSIONS: Few patients had a recurrent stroke shortly after the previous stroke in this study. This indicates that it is meaningful to prevent a second event with an adequate long-term treatment strategy for secondary prevention after first-ever stroke. There also seems to be a clear potential for improving secondary prevention after stroke.
BACKGROUND: Much effort has been made to study first-ever strokepatients. However, recurrent stroke has not been investigated as extensively. It is unclear which risk factors dominate, and whether adequate secondary prevention has been provided to patients who suffer from recurrent stroke. Also, the different types of recurrent stroke need further evaluation. METHODS: The study included patients with recurrent stroke admitted to twenty-three Swedish stroke centers. The type of previous and recurrent stroke was determined, as well as evaluation (when applicable) of recurrent ischemic stroke according to the TOAST classification. Presence of vascular risk factors was registered and compared to the type of stroke. Also assessed was ongoing secondary prevention treatment at recurrent stroke onset. RESULTS: A total of 889 patients with recurrent stroke (mean age 77) were included in the study. Of these, 805 (91%) had ischemic stroke, 78 (9%) had intracerebral hemorrhage and 6 (<1%) stroke of unknown origin. The most frequent vascular risk factors were hypertension (75%) and hyperlipidemia (56%). Among the 889 patients, 29% had atrial fibrillation. Of the patients in the ischemic group with cardiac embolism, only 21% were on anticoagulation treatment. The majority of the patients (75%) had their most recent previous stroke >12 months before admission. CONCLUSIONS: Few patients had a recurrent stroke shortly after the previous stroke in this study. This indicates that it is meaningful to prevent a second event with an adequate long-term treatment strategy for secondary prevention after first-ever stroke. There also seems to be a clear potential for improving secondary prevention after stroke.
Authors: Carl van Walraven; Robert G Hart; Daniel E Singer; Andreas Laupacis; Stuart Connolly; Palle Petersen; Peter J Koudstaal; Yuchiao Chang; Beppie Hellemons Journal: JAMA Date: 2002-11-20 Impact factor: 56.272
Authors: G J Hankey; K Jamrozik; R J Broadhurst; S Forbes; P W Burvill; C S Anderson; E G Stewart-Wynne Journal: Stroke Date: 2000-09 Impact factor: 7.914
Authors: Faisal M Shuaib; Raegan W Durant; Gaurav Parmar; Todd M Brown; David L Roth; Martha Hovater; Jewell H Halanych; James M Shikany; George Howard; Monika M Safford Journal: J Health Care Poor Underserved Date: 2012-05
Authors: Timothy J Bernard; Lauren A Beslow; Marilyn J Manco-Johnson; Jennifer Armstrong-Wells; Richard Boada; David Weitzenkamp; Amanda Hollatz; Sharon Poisson; Catherine Amlie-Lefond; Warren Lo; Gabrielle deVeber; Neil A Goldenberg; Michael M Dowling; E Steve Roach; Heather J Fullerton; Susanne M Benseler; Lori C Jordan; Adam Kirton; Rebecca N Ichord Journal: Stroke Date: 2016-09-15 Impact factor: 7.914
Authors: Timothy J Bernard; Marilyn J Manco-Johnson; Warren Lo; Mark T MacKay; Vijeya Ganesan; Gabrielle DeVeber; Neil A Goldenberg; Jennifer Armstrong-Wells; Michael M Dowling; E Steve Roach; Mark Tripputi; Heather J Fullerton; Karen L Furie; Susanne M Benseler; Lori C Jordan; Adam Kirton; Rebecca Ichord Journal: Stroke Date: 2011-12-08 Impact factor: 7.914
Authors: James Lewsey; Pardeep S Jhund; Michelle Gillies; Jim W T Chalmers; Adam Redpath; Andrew Briggs; Matthew Walters; Peter Langhorne; Simon Capewell; John J V McMurray; Kate MacIntyre Journal: BMC Med Date: 2010-04-09 Impact factor: 8.775
Authors: Niamh Hannon; Orla Sheehan; Lisa Kelly; Michael Marnane; Aine Merwick; Alan Moore; Lorraine Kyne; Joseph Duggan; Joan Moroney; Patricia M E McCormack; Leslie Daly; Nicola Fitz-Simon; Dawn Harris; Gillian Horgan; Emma B Williams; Karen L Furie; Peter J Kelly Journal: Cerebrovasc Dis Date: 2009-11-05 Impact factor: 2.762